Hospitalization and Survival in Patients Using Epoprostenol for Injection in the PROSPECT Observational Study

BACKGROUND: Few studies have prospectively reported outcomes in patients with pulmonary arterial hypertension (PAH) treated with epoprostenol in the modern-day era of oral therapy and combination treatments. The Registry to Prospectively Describe Use of Epoprostenol for Injection (Veletri, prolonged...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Chest
Egile Nagusiak: Frantz, Robert P., Schilz, Robert J., Chakinala, Murali M., Badesch, David B., Frost, Adaani E., McLaughlin, Vallerie V., Barst, Robyn J., Rosenberg, Daniel M., Miller, Dave P., Hartline, Brian K., Benton, Wade W., Farber, Harrison W.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American College of Chest Physicians 2015
Gaiak:
Original Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4314821/
https://ncbi.nlm.nih.gov/pubmed/25320967
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1378/chest.14-1004
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak